Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - Home
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Podcasts
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Interviews
    • Meetings reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - Home
  • Pharmaceuticals
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • AdobeStock_572744272
      Biosimilars CMC development considerations from the sponsor perspective
    • AdobeStock_209340094
      Navigating the global supply of starting materials for cell-based therapies
    • AdobeStock_414656141_Editorial_Use_Only (1)
      Warning letters for direct-to-consumer advertising: a five-year retrospective analysis
  • Veterinary
    • AdobeStock_107405647
      EMA future ‘VetMeds’ for healthy animals and humans; seminar
    • AdobeStock_222675053
      Human COVID drug set to treat FCov-23 coronavirus in cats
    • AdobeStock_86056969
      Reappraisal of regulation of agricultural and veterinary chemicals in Australia
    • NEWS-Mutual-Recognition
      Umbrella EU-US VetMed MRA comes one step closer
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
    • COVID breath test-Wash U
      Rapid COVID-19 breath test device shows promise
    • EU-IVDR-3-to-2
      A year of clinical trials under IVDR:
      a sponsor’s perspective
    • Hearing aid
      Regulatory challenges and opportunities facing hearing aid manufacturers in Europe
  • Industry news
      • Industry news
        • Read latest news
        • Podcasts
        • Video
    • Sept-Podcast-artwork-Webvision
      RegRapPod − September 2023
    • AdobeStock_322101536
      EMA suggests novel method to assess CKD therapies effectiveness
    • Woman receiving radiotherapy treatment for lung cancer
      NICE recommends AI to aid radiotherapy treatment in England
  • Commentary
      • Editorials
      • Letters to the Editor
    • AdobeStock_585476774
      The worldwide web of regulation
    • RR-JUNE-2023-COVER
      Clinical trials:
      Ethical, ecological
      and economic change
    • Legalise-Cannabis
      Part 4. UK routes to registration for medicinal cannabis
  • Collections
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Interviews
      • Meetings reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Product Information Stories

  • Patient information, why do things go wrong?

    Patient information — why do things go wrong?

    2023-02-07T09:26:00+00:00By Rory Littlebury

  • AdobeStock_180072866

    Part 1: EU reclassification (Rx to OTC switch) regulatory framework – what are the key challenges for industry and how might these be overcome?

    2022-06-22T14:53:00+01:00By Sarah Landra (née Laird)

  • AdobeStock_294542021

    Electronic leaflet pilot in Belgium and Luxembourg hospitals

    2022-03-23T11:07:00+00:00By Nathalie Lambot, Marie Vande Ginste

  • Regulatory Rapporteur Editorial board
  • Future focus topics
  • Glossary
  • Privacy policy
  • Search the archive
  • TOPRA membership
  • What is regulatory affairs?
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Issues
  • Contact us
  • Topics A-Z
  • Contributors A-Z
  • Copyright © 2023 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud